Skip to main content

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 29))

  • 59 Accesses

Abstract

The most important problem in current therapy of childhood acute lymphoblastic leukemia (ALL) is a failure in over one-half of patients. We were unable to increase the failure-free survival of children with high risk ALL by a ten-drug regimen (modified LSA2L2) above 30% at 6 years [1].

Universitäts-Kinderklinik Jena, Abt. Hämatologie/Onkologie/Immunologie, Kochstraß 2, 6900 Jena, GDR

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Zintl F, Hermann J, Katenkamp D, Malke H, Plenert W (1983) Results of LSA2L2 therapy in children with high risk acute lymphoblastic leukemia and non-Hodgkin’s lymphoma. In: Neth R, Gallo RC, Greaves MF, Moore MAS, Winkler K (eds) Modern trends in human leukemia, vol V. Springer, Berlin Heidelberg New York Tokyo, pp 62–66

    Google Scholar 

  2. Riehm H, Gadner H, Henze G, Langermann HJ, Odenwald E (1980) The Berlin childhood acute lymphoblastic leukemia therapy study, 1970–1976. Am J Ped Hematol Oncol 2: 299–306

    Google Scholar 

  3. Riehm H, Henze G, Langermann HJ (1981) Multizentrische Therapiestudie BFM 81 zur Behandlung der akuten lymphoblastischen Leukämie im Kindes- und Jugendalter. Studienprotokoll, 1981

    Google Scholar 

  4. Langermann HJ, Henze G, Wulf M, Riehm H (1982) Abschätzung der Tumorzellmasse bei der akuten lymphoblastischen Leukämie im Kindesalter: prognostische Bedeutung und praktische Anwendung. Klin Pädiatr 194: 209–213

    Article  PubMed  CAS  Google Scholar 

  5. Henze G, Langermann HJ, Fengler R et al. (1982) Therapiestudie BFM 79/81 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: intensivierte Reinduktionstherapie für Patientengruppen mit unterschiedlichem Rezidivrisiko. Klin Pädiatr 194: 195–203

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Zintl, F., Malke, H., Plenert, W. (1985). Clinical Experiences with a Modified BFM Protocol in Childhood Acute Lymphoblastic Leukemia. In: Neth, R., Gallo, R.C., Greaves, M.F., Janka, G. (eds) Modern Trends in Human Leukemia VI New Results in Clinical and Biological Research Including Pediatric Oncology. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 29. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70385-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70385-0_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-15329-0

  • Online ISBN: 978-3-642-70385-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics